A third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels significantly in those who have previously received two doses of Sinovac's CoronaVac shot, a study has found.
The study found that CoronaVac received the strongest boost from a viral vector or RNA shot, including against the Delta and Omicron coronavirus variants, researchers from Brazil and Oxford University said on Monday.
China-based Sinovac's vaccine uses an inactivated version of a coronavirus strain that was isolated from a patient in China. It is currently approved in more than 50 countries including Brazil, China, Argentina, South Africa, Oman, Malaysia, Indonesia and Turkey.
"This study provides important options for policymakers in the many countries where inactivated vaccines ... have been used," said Andrew Pollard, director of the Oxford Vaccine Group and study lead.
However, another study in December found that Sinovac's two-dose shot followed by a booster dose of Pfizer-BioNTech's vaccine showed a lower immune response against the Omicron variant compared with other strains.
Viral vector vaccines such as the ones developed by AstraZeneca-Oxford and J&J use a weakened version of another virus to deliver genetic instructions for making proteins from the virus against which protection is sought.
Pfizer and BioNTech's mRNA vaccines deliver a genetic transcript with instructions for making viral proteins to teach the body how to defend against infections.
A third dose of CoronaVac also increased antibodies, but the results were better when a different vaccine was used, according to the latest study that included 1,240 volunteers from the Brazilian cities of Sao Paulo and Salvador.
Antibody levels were low before the booster doses, with only 20.4% of adults aged 18-60 and 8.9% of adults aged over 60 having detectable levels of neutralising antibodies. These were seen to significantly increase across every booster vaccine regimen, according to the study, which was published in the Lancet medical journal on Friday.
Reuters
Tue Jan 25 2022
China-based Sinovac's vaccine uses an inactivated version of a coronavirus strain that was isolated from a patient in China. - REUTERS
Mangsa banjir di Johor, Melaka sedikit meningkat malam ini
Di Johor, mangsa banjir yang ditempatkan di lapan PPS meningkat sedikit kepada 582 orang daripada 158 keluarga pada pukul 8 malam Isnin.
Wanita rugi RM280,000 terperdaya sindiket penipuan panggilan telefon
Seorang eksekutif pembinaan di Bahau, Jempol, kerugian RM280,000 selepas diperdaya sindiket penipuan melalui panggilan telefon yang menyamar sebagai pegawai polis, semalam.
Agenda AWANI: One Year Of Genoside In Gaza
After a year of the genocidal war in Gaza, the conflict has intensified, drawing in multiple countries across the Middle East. What’s next? Tune in to Agenda Awani at 9 PM tonight for an exclusive interview with Dr. Abdullah Waleed, a member of Palestine’s Council on International Relations.
PM Anwar kutuk hipokrasi Barat di Gaza dalam temu bual dengan penyiar berpangkalan di AS
Perdana Menteri menekankan peranan Malaysia dalam menyuarakan keadilan, walaupun merupakan sebuah negara kecil.
Jangan angkuh, bongkak dengan kemenangan di DUN Mahkota - MKT UMNO
MKT juga berpandangan kemenangan di DUN Mahkota memberikan isyarat jelas bahawa rakyat menerima baik model kerjasama Kerajaan Perpaduan.
Tengku Natasya pilihan hati Tengku Muhammad Iskandar
Istana Abdulaziz Kuantan sekali lagi bakal dihiasi seri pengantin diraja pada 24, 25 dan 27 Oktober ini.
Hezbollah serang bandar Haifa Israel
Kumpulan Hezbollah dari Lubnan pada Isnin menyerang bandar Haifa di utara Israel dengan serangan roket besar-besaran, menurut kumpulan itu dalam satu kenyataan.
AWANI Ringkas: 'Hot Daddy', dua wanita kena waran tangkap
Ikuti rangkuman berita utama yang menjadi tumpuan sepanjang hari di Astro AWANI menerusi AWANI Ringkas.
Status ajaran GISB: Negeri Sembilan tunggu perkenan Tuanku Muhriz
Menteri Besar Negeri Sembilan Datuk Seri Aminuddin Harun berkata pihaknya perlu mendapatkan pandangan daripada Jabatan Mufti dan Majlis Fatwa negeri sebelum sebarang keputusan dibuat.
Hampir RM40 juta diperuntuk bagi projek di Sabah - Ahmad Maslan
Kerajaan memperuntukkan hampir RM40 juta bagi melaksanakan pelbagai projek infrastruktur awam di Sabah termasuk pembinaan Lebuh Raya Pan Borneo (LPB) Fasa 1A dan Fasa 1B.
CITF-C perinci pemberian vaksin Sinovac untuk kanak-kanak
Perincian perihal pemberian vaksin Sinovac kepada kanak-kanak berumur lima hingga 11 tahun akan diputuskan selepas mesyuarat Jawatankuasa Bertindak Imunisasi COVID-19 Kanak-Kanak (CITF-C) malam ini.
Sinovac antara vaksin paling selamat untuk golongan pediatrik - Pharmaniaga
Golongan kanak-kanak dan remaja perlu divaksin untuk mengecilkan lagi risiko permutasian dan kebolehjangkitan virus COVID-19 dalam masyarakat.
Kajian terbaharu tiga dos vaksin Sinovac COVID-19 berkesan ke atas Omicron
Data penyelidikan terbaharu diterbitkan Sinovac Biotech Ltd menunjukkan bahawa tiga dos vaksin Sinovac COVID-19 menghasilkan antibodi peneutral yang lebih tinggi dalam 95 peratus penerima.
Harga runcit, borong maksimum untuk vaksin COVID-19 Sinovac Sinopharm ditetapkan
Harga runcit dan borong maksimum bagi dua produk vaksin COVID-19 jenama CoronaVac keluaran Sinovac dan Covilo keluaran Sinopharm akan ditetapkan berkuat kuasa Sabtu ini (15 Jan).
Tiga dos vaksin Sinovac mampu beri 94 peratus perlindungan terhadap varian Omicron
Kajian terbaharu menunjukkan tiga dos vaksin keluaran syarikat biotech Sinovac mampu menghasilkan antibodi peneutralan sebanyak 94 peratus terhadap varian COVID-19 Omicron.
KKM kumpul 663 sampel bagi kajian vaksin Sinovac kanak-kanak
Kementerian Kesihatan (KKM) telah mengumpul 663 sampel di seluruh negara untuk kajian bagi menentukan sama ada vaksin Sinovac sesuai diberikan kepada golongan kanak-kanak berusia tiga hingga 11 tahun.
Vaksin COVID-19: Pejabat Kesihatan Tawau sasar 30,000 penerima dos penggalak
Jumlah itu terdiri daripada penerima vaksin Sinovac dan Pfizer-BioNTech daripada golongan warga emas.
Vaksin COVID-19: Hong Kong turunkan had umur ambil vaksin mulai usia 3 tahun
Remaja berumur 12 hingga 17 tahun akan diberi keutamaan untuk menerima vaksin CoronaVac.
Ambil dos penggalak, ikuti kawalan wabak
Perkembangan situasi pandemik di dunia kini telah membuktikan pentingnya penggunaan dos penggalak.
Sinovac, Astrazeneca dipertimbang sebagai dos penggalak - Khairy
Kementerian Kesihatan (KKM) sedang mempertimbangkan vaksin Sinovac dan AstraZeneca digunakan untuk suntikan dos penggalak, kata menteri berkenaan Khairy Jamaluddin.